Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy

L. Dirven, N.B. Klarenbeek, M. van den Broek, J.H.L.M. Groenendael, P.B.J. de Sonnaville, P.J.S.M. Kerstens, T.W.J. Huizinga, B.A.C. Dijkmans, W.F. Lems, C.F. Allaart

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)585-590
JournalClinical Rheumatology
Volume32
Issue number5
DOIs
Publication statusPublished - 2013

Cite this

Dirven, L., Klarenbeek, N. B., van den Broek, M., Groenendael, J. H. L. M., de Sonnaville, P. B. J., Kerstens, P. J. S. M., ... Allaart, C. F. (2013). Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy. Clinical Rheumatology, 32(5), 585-590. https://doi.org/10.1007/s10067-012-2136-8
Dirven, L. ; Klarenbeek, N.B. ; van den Broek, M. ; Groenendael, J.H.L.M. ; de Sonnaville, P.B.J. ; Kerstens, P.J.S.M. ; Huizinga, T.W.J. ; Dijkmans, B.A.C. ; Lems, W.F. ; Allaart, C.F. / Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy. In: Clinical Rheumatology. 2013 ; Vol. 32, No. 5. pp. 585-590.
@article{facc737697424a40b70e06a38dd31b0f,
title = "Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy",
author = "L. Dirven and N.B. Klarenbeek and {van den Broek}, M. and J.H.L.M. Groenendael and {de Sonnaville}, P.B.J. and P.J.S.M. Kerstens and T.W.J. Huizinga and B.A.C. Dijkmans and W.F. Lems and C.F. Allaart",
year = "2013",
doi = "10.1007/s10067-012-2136-8",
language = "Undefined/Unknown",
volume = "32",
pages = "585--590",
journal = "Clinical Rheumatology",
issn = "0770-3198",
publisher = "Springer London",
number = "5",

}

Dirven, L, Klarenbeek, NB, van den Broek, M, Groenendael, JHLM, de Sonnaville, PBJ, Kerstens, PJSM, Huizinga, TWJ, Dijkmans, BAC, Lems, WF & Allaart, CF 2013, 'Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy' Clinical Rheumatology, vol. 32, no. 5, pp. 585-590. https://doi.org/10.1007/s10067-012-2136-8

Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy. / Dirven, L.; Klarenbeek, N.B.; van den Broek, M.; Groenendael, J.H.L.M.; de Sonnaville, P.B.J.; Kerstens, P.J.S.M.; Huizinga, T.W.J.; Dijkmans, B.A.C.; Lems, W.F.; Allaart, C.F.

In: Clinical Rheumatology, Vol. 32, No. 5, 2013, p. 585-590.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy

AU - Dirven, L.

AU - Klarenbeek, N.B.

AU - van den Broek, M.

AU - Groenendael, J.H.L.M.

AU - de Sonnaville, P.B.J.

AU - Kerstens, P.J.S.M.

AU - Huizinga, T.W.J.

AU - Dijkmans, B.A.C.

AU - Lems, W.F.

AU - Allaart, C.F.

PY - 2013

Y1 - 2013

U2 - 10.1007/s10067-012-2136-8

DO - 10.1007/s10067-012-2136-8

M3 - Article

VL - 32

SP - 585

EP - 590

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 0770-3198

IS - 5

ER -